Innate Pharma plans Phase 3 trial after Sobi deal
Innate Pharma (NASDAQ:IPHA) announced plans to begin the TELLOMAK-3 confirmatory Phase 3 study of lacutamab in cutaneous T-cell lymphoma, subject to completion of its strategic partnership with Sobi.
Todas as matérias desta seção, das mais recentes às mais antigas — página 93 de 371.
Innate Pharma (NASDAQ:IPHA) announced plans to begin the TELLOMAK-3 confirmatory Phase 3 study of lacutamab in cutaneous T-cell lymphoma, subject to completion of its strategic partnership with Sobi.
ASE Technology Holding (NYSE:ASX) reported unaudited July 2026 net revenue of NT$73.8 billion, up 43.2% year over year and 12.2% from June 2026.
Oculis (NASDAQ:OCS) signed an agreement to acquire worldwide development and commercial rights to Privosegtor (ACT-01) from Accure Therapeutics, along with rights to an early-stage neurology candidate known as ACT-02.
Cadeler (NYSE:CDLR) signed contracts worth approximately €805 million with COSCO Shipping Offshore shipyard in Qidong, China, for two new T-class offshore wind installation vessels scheduled for delivery in 2030 and 2031.
Niu Technologies (NASDAQ:NIU) reported Q2 2026 revenue of RMB1,440.4 million, up 14.7%, as e-scooter sales volume increased to 434,687 units.
Oil prices were largely unchanged Monday as traders assessed possible progress toward reopening the Strait of Hormuz while monitoring continued Middle East tensions.
Sohu (NASDAQ:SOHU) today revealed Q2 2026 total revenue of $136 million, up 7% year over year, while GAAP net income attributable to shareholders reached $0.2 million.
Seadrill (NYSE:SDRL) reported Q2 2026 operating revenue of $449 million, up 19.1% year over year, with net income of $29 million and adjusted EBITDA of $144 million.
ANI Pharmaceuticals (NASDAQ:ANIP) reported record Q2 2026 net revenue of $266.0 million, up 25.9%, while GAAP net income reached $24.7 million.
Oklo (NYSE:OKLO) reported Q2 2026 revenue of $1.2 million while recording a loss of $0.28 per share, compared with an analyst loss estimate of $0.16.
Array Digital Infrastructure (NYSE:AD) reported Q2 2026 operating revenue from continuing operations of $54.1 million, up about 90%, as site rental revenue increased 95% to $53.2 million.
Construction Partners (NASDAQ:ROAD) reported fiscal Q3 2026 revenue of $999.4 million, up 28.2%, while net income increased to $59.6 million.
Take-Two Interactive Software (NASDAQ:TTWO) reported fiscal Q1 2027 GAAP net revenue of $1.53 billion, up about 2%, while net bookings fell 3% to $1.39 billion.
Atmus Filtration Technologies (NYSE:ATMU) reported record Q2 2026 net sales of $527.9 million, up 16.4%, while GAAP net income increased to $64 million.
Johnson Outdoors (NASDAQ:JOUT) reported fiscal Q3 2026 net sales of $189.7 million, up 5%, while operating income increased to $18.3 million from $7.3 million.
Calumet (NASDAQ:CLMT) reported a Q2 2026 net loss of $95.9 million, or $1.09 per share, compared with a $147.9 million loss a year earlier.
Nathan’s Famous (NASDAQ:NATH) reported fiscal Q1 2027 revenue of $54.1 million, up about 15%, while net income edged down to $8.8 million.
The Wendy’s Company (NASDAQ:WEN) reported Q2 2026 revenue of $570.6 million, up 1.7%, while global systemwide sales declined 6.5% to about $3.4 billion.
Under Armour (NYSE:UAA) reported fiscal Q1 2027 revenue of $1.10 billion, down 3%, while operating income reached $47 million.
Gray Media (NYSE:GTN) reported Q2 2026 revenue of $839 million, up 9% year over year, while adjusted EBITDA increased 27% to $214 million.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade